跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ZYPREXA 5 MG COMPRIMIDOS RECUBIERTOS - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
ZYPREXA 5 MG COMPRIMIDOS RECUBIERTOS
Approved
STANDARD
ZYPREXA 5 MG COMPRIMIDOS RECUBIERTOS
Eli Lilly Nederland B.V.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jan 8, 2024
Approval ID
f0ea7eb2a7cd9c68
Company
Eli Lilly Nederland B.V.
Type
Standard
Approval Details
Approval Id
f0ea7eb2a7cd9c68
Drug Cima Aemps Name
ZYPREXA 5 MG COMPRIMIDOS RECUBIERTOS
Register Number
96022004IP5
Holder Company Name
Eli Lilly Nederland B.V.
Marketing Company Name
Abacus Medicine A/S
Holder Company Detail Path
/organization/eli-lilly-nederland-bv
Authorization Date
2024-01-08
Dosage Form
COMPRIMIDO RECUBIERTO
Dose
5 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Eli Lilly Nederland B.V.
Company Detail Path
/organization/eli-lilly-nederland-bv
Company Information
Pharmaceutical Company Name
Eli Lilly Nederland BV
Country Name
Netherlands
Website
http://www.lilly.com/nl
Active Ingredients
OLANZAPINA
5 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jan 8, 2024
Approval ID
f0ea7eb2a7cd9c68
Type
Standard
Back to CIMA-AEMPS Approvals